Tapestry Pharmaceuticals (TPPH) Withdrawals Proposed $40 Million Stock Offering
Tapestry Pharmaceuticals, Inc. (Nasdaq: TPPH) has withdrawn its registration statement on Form S-1 that had been filed with the SEC in conjunction with a proposed offering of $40 million of common stock.
"Given the encouraging data we recently presented at the annual meetings of both the American Association for Cancer Research (AACR) and American Society of Clinical Oncology (ASCO) and the Company's overall financial position, we have decided to withdraw the proposed public offering and consider other financing options," commented Leonard Shaykin, Chairman and CEO.
"Given the encouraging data we recently presented at the annual meetings of both the American Association for Cancer Research (AACR) and American Society of Clinical Oncology (ASCO) and the Company's overall financial position, we have decided to withdraw the proposed public offering and consider other financing options," commented Leonard Shaykin, Chairman and CEO.
You May Also Be Interested In
- New York Mortgage Trust (NYMT) Prices 2.75M Offering at $6.65/Share
- Alexion Pharmaceuticals (ALXN) Prices 5M Share Offering at $93.02
- STAG Industrial (STAG) Prices 7.25M Shares at $12.88
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
